补阳还五汤治疗缺血性中风的临床研究进展
Clinical Research on the Treatment of Ischemic Stroke with Buyang Huanwu Decoction
DOI: 10.12677/tcm.2026.155251, PDF,    科研立项经费支持
作者: 王建涛, 窦荣海, 吴晓刚*:兰州石化总医院(甘肃中医药大学第四附属医院)康复医学科,甘肃 兰州
关键词: 补阳还五汤中风中医基础理论作用机制Buyang Huanwu Decoction Stroke Basic Theory of Traditional Chinese Medicine Mechanism of Action
摘要: 中风是导致全球范围内高致残率与高死亡率的急性脑血管疾病,其中气虚血瘀证是脑卒中后期最常见的证型。具有益气、活血、通络之功效的补阳还五汤在治疗中风后遗症方面具有显著疗效。将有深厚根基的中医理论与现代药理学研究成果相结合,深入探讨补阳还五汤中的单味药、有效成分及其相关药对,综述其通过促进神经修复、改善微循环、抑制氧化应激及调节细胞凋亡等机制,发挥明显的神经保护与功能重建。补阳还五汤方中的单味药物以及核心药对,都能在一定程度上改善中风后出现的神经缺损症状,如偏瘫、口眼歪斜、语言不利等。其作用机制主要聚焦于神经–血管单元,凭借对神经营养因子的调节、血管新生的促进、炎症反应的抑制以及胶质瘢痕的干预,进而发挥出益气活血、化瘀通络的治疗功效。
Abstract: Stroke is an acute cerebrovascular disease that leads to high disability and mortality rates worldwide. Qi deficiency and blood stasis syndrome is the most common syndrome type in the later stage of stroke. Buyang Huanwu Decoction, which has the functions of tonifying qi, promoting blood circulation and unblocking meridians, has a significant therapeutic effect on post-stroke sequelae. By integrating the profound traditional Chinese medicine theory with modern pharmacological research achievements, this paper deeply explores the single herbs, active ingredients and related drug pairs in Buyang Huanwu Decoction, and reviews its significant neuroprotective and functional reconstruction effects through mechanisms such as promoting neural repair, improving microcirculation, inhibiting oxidative stress and regulating cell apoptosis. The single herbs in Buyang Huanwu Decoction and their active ingredients, as well as core drug pairs, can all improve to some extent the neurological deficits after stroke, such as hemiplegia, facial distortion, and speech impairment. The mechanism of action mainly focuses on the neuro-vascular unit, by regulating neurotrophic factors, promoting angiogenesis, inhibiting inflammatory responses and intervening in glial scar formation, thereby exerting the therapeutic effects of tonifying qi, promoting blood circulation, removing blood stasis and unblocking meridians.
文章引用:王建涛, 窦荣海, 吴晓刚. 补阳还五汤治疗缺血性中风的临床研究进展[J]. 中医学, 2026, 15(5): 52-63. https://doi.org/10.12677/tcm.2026.155251

参考文献

[1] Owolabi, M.O., Thrift, A.G., Martins, S., Johnson, W., Pandian, J., Abd-Allah, F., et al. (2021) The State of Stroke Services across the Globe: Report of World Stroke Organization-World Health Organization Surveys. International Journal of Stroke, 16, 889-901. [Google Scholar] [CrossRef] [PubMed]
[2] Ma, Q., Li, R., Wang, L., Yin, P., Wang, Y., Yan, C., et al. (2021) Temporal Trend and Attributable Risk Factors of Stroke Burden in China, 1990-2019: An Analysis for the Global Burden of Disease Study 2019. The Lancet Public Health, 6, e897-e906. [Google Scholar] [CrossRef] [PubMed]
[3] 叶青, 陆家武. 补阳还五汤治疗缺血性脑卒中的作用机制研究[J]. 中国民间疗法, 2025, 33(6): 123-126.
[4] 张超, 李瑞青, 张丹莉. 基于RIP1/RIP3/MLKL通路研究桑色素对缺血性脑卒中大鼠神经元坏死性凋亡的影响及作用机制[J]. 中草药, 2025, 56(16): 5847-5855.
[5] Xue, Y., Nie, D., Wang, L.J., et al. (2021) Microglial Polarization: Novel Therapeutic Strategy against Ischemic Stroke. Aging and Disease, 12, 466-479.
[6] 张梦云, 王东岩, 董旭, 等. 基于血脑屏障探讨针刺治疗缺血性脑卒中机制的研究进展[J]. 辽宁中医药大学学报, 2025, 27(10): 177-181.
[7] 沈永玲, 方建伟, 程飞, 等. 急性缺血性脑卒中患者血清脑源性神经营养因子、单核细胞与HDL-C比值与卒中后认知障碍的相关性[J]. 川北医学院学报, 2025, 40(5): 624-627.
[8] 胡文静, 王亚男, 王建涛, 等. 基于“高巅之上, 唯风可到”汗下同用治疗缺血性中风的探讨[J]. 长春中医药大学学报, 2025, 41(7): 719-722.
[9] 何伟伟, 胡鑫洁, 安莹, 等. 中风病证候的现代文献研究及证候规范化问题的探讨[J]. 时珍国医国药, 2024, 35(11): 2687-2691.
[10] 刘珍珍. 补阳还五汤治疗缺血性脑卒中气虚血瘀证临床观察[J]. 中国中医药现代远程教育, 2025, 23(10): 58-60.
[11] 林钰莹, 陈全福. 补阳还五汤联合瑞舒伐他汀治疗冠心病心绞痛疗效研究[J]. 陕西中医, 2025, 46(7): 924-928.
[12] 毕亚荣, 杨沙丽. 补阳还五汤加减辅治糖尿病性下肢动脉硬化闭塞症临床研究[J]. 实用中医药杂志, 2025, 41(7): 1450-1452.
[13] 潘菲, 韩扬, 史佩玉, 等. 补阳还五汤治疗糖尿病周围神经病变疗效观察及对ATG13甲基化水平、自噬相关蛋白表达的影响[J]. 新中医, 2025, 57(14): 20-24.
[14] 范锐, 田梅, 张伟. 张伟应用补阳还五汤治疗气虚血瘀型肺纤维化经验[J]. 山东中医杂志, 2025, 44(8): 835-839.
[15] 周建伟, 周秩权, 张锦. 加味补阳还五汤治疗气阴两虚兼瘀血痹阻型肺结核65例[J]. 湖南中医杂志, 2025, 41(5): 13-16+64.
[16] 周涛, 聂士超, 权义涛, 等. 补阳还五汤促进老年股骨粗隆间骨折术后康复的临床观察[J]. 安徽中医药大学学报, 2025, 44(3): 27-31.
[17] 单海雷, 焦光美, 程曦, 等. 大豆异黄酮基于RhoA/ROCK2信号通路改善MCAO大鼠神经功能损伤[J]. 现代生物医学进展, 2020, 20(17): 3233-3238.
[18] Yang, S.E., Lien, J.C., Tsai, C.W., et al. (2022) Therapeutic Potential and Mechanisms of Novel Simple O-Substituted Isoflavones against Cerebral Ischemia Reperfusion. International Journal of Molecular Sciences, 23, Article 10394. [Google Scholar] [CrossRef] [PubMed]
[19] 张彐宁, 靳晓飞, 张怡, 等. 黄芪中毛蕊异黄酮不同剂量对脑缺血再灌注大鼠神经细胞的保护作用[J]. 河北中医药学报, 2022, 37(3): 43-47.
[20] Hou, B., Liu, R., Wu, Y. and Huang, S. (2020) Astragaloside IV Reduces Cerebral Ischemia/Reperfusion-Induced Blood-Brain Barrier Permeability in Rats by Inhibiting ER Stress-Mediated Apoptosis. Evidence-Based Complementary and Alternative Medicine, 2020, Article 9087873. [Google Scholar] [CrossRef] [PubMed]
[21] Yang, L., Dong, X. and Zhang, W. (2020) Astragaloside IV Alleviates the Brain Damage Induced by Subarachnoid Hemorrhage via PI3K/Akt Signaling Pathway. Neuroscience Letters, 735, Article 135227. [Google Scholar] [CrossRef] [PubMed]
[22] Chen, F., Yang, D., Cheng, X., Yang, H., Yang, X., Liu, H., et al. (2021) Astragaloside IV Ameliorates Cognitive Impairment and Neuroinflammation in an Oligomeric Aβ Induced Alzheimer’s Disease Mouse Model via Inhibition of Microglial Activation and NADPH Oxidase Expression. Biological and Pharmaceutical Bulletin, 44, 1688-1696. [Google Scholar] [CrossRef] [PubMed]
[23] 张悦, 付晓琪, 徐紫晨, 等. 赤芍的化学成分、药理作用和质量标志物的预测分析[J]. 中国新药杂志, 2025, 34(15): 1602-1607.
[24] 彭莹娟, 李志营, 孙林林, 等. 赤芍总苷减轻脑缺血/再灌注模型大鼠脑损伤[J]. 基础医学与临床, 2025, 45(1): 25-30.
[25] 薛剑, 马伟, 徐世一, 等. 赤芍活性成分治疗中枢神经系统疾病的研究进展[J]. 中草药, 2024, 55(19): 6806-6819.
[26] Xiao, Y., Wang, Y., Li, L., Jin, Y., Sironi, L., Wang, Y., et al. (2014) Lactones from Ligusticum Chuanxiong Hort. Reduces Atherosclerotic Lesions in apoE-Deficient Mice via Inhibiting over Expression of NF-kB-Dependent Adhesion Molecules. Fitoterapia, 95, 240-246. [Google Scholar] [CrossRef] [PubMed]
[27] Wu, X., Pan, X., Kang, J., Huang, Y., Ren, J., Pan, J., et al. (2025) Ferulic Acid Inhibits ox-LDL-Induced Ferroptosis and Apoptosis in RAW 264.7 Cells via the HIF-1 Signaling Pathway. Frontiers in Pharmacology, 16, Article 1524736. [Google Scholar] [CrossRef] [PubMed]
[28] Wu, Q., Liu, J., Mao, Z., Tian, L., Wang, N., Wang, G., et al. (2022) Ligustilide Attenuates Ischemic Stroke Injury by Promoting Drp1-Mediated Mitochondrial Fission via Activation of AMPK. Phytomedicine, 95, Article 153884. [Google Scholar] [CrossRef] [PubMed]
[29] 李晶晶, 雷涛, 林俊等. 当归多糖通过促血管再生保护大鼠脑缺血再灌注损伤机制研究[J]. 中华中医药学刊, 2019, 37(09): 2272-2276+2317.
[30] 董建华, 惠渊, 周学锐, 等. 当归多糖抗脑缺血再灌注损伤作用机制研究进展[J]. 中国中医药图书情报杂志, 2025, 49(2): 234-238.
[31] Li, L.L., Liu, Y.R., Sun, C., et al. (2020) Taoren-Dahuang Herb Pair Reduces Eicosanoid Metabolite Shifts by Regulating ADORA2A Degradation Activity in Ischaemia/Reperfusion Injury Rats. Journal of Ethnopharmacology, 260, Article 113014. [Google Scholar] [CrossRef] [PubMed]
[32] 周国铭, 王玺, 何成峙, 等. 桃仁现代研究进展和炮制方法历史沿革[J]. 中草药, 2024, 55(13): 4565-4574.
[33] 邹莉芳, 卢昌均, 黄锦, 等. 通窍活血汤治疗血管性痴呆的现代药理学研究进展[J]. 中医临床研究, 2023, 15(9): 86-89.
[34] Yang, W., Wang, W., Ma, Y., Yang, Q., Li, P. and Du, S. (2021) Bioevaluation of Pheretima Vulgaris Antithrombotic Extract, PvQ, and Isolation, Identification of Six Novel PvQ-Derived Fibrinolytic Proteases. Molecules, 26, Article 4946. [Google Scholar] [CrossRef] [PubMed]
[35] 吴娅丽, 马韫楠, 李伟霞, 等. 基于网络药理学和蛋白组学的地龙抗血栓作用机制研究[J]. 中华中医药学刊, 2023, 41(10): 76-82+273-274.
[36] Dong, L.L., Qiu, M.M., Liu, Y.L., et al. (2022) Attenuation of Histone H4 Lysine 16 Acetylation (H4K16ac) Elicits a Neuroprotection against Ischemic Stroke by Alleviating the Autophagic/Lysosomal Dysfunction in Neurons at the Penumbra. Brain Research Bulletin, 184, 24-33. [Google Scholar] [CrossRef] [PubMed]
[37] Liu, L., Wang, R., Gao, W., Hou, X., Jin, X., Zhao, Y., et al. (2025) Drug Pairs of Huangqi and Dnggui Alleviates Pyroptosis by Promoting Autophagy Activity via AMPK/mTOR Signaling Pathway in Middle-Cerebral Artery Occlusion/Reperfusion in Rats. Journal of Ethnopharmacology, 337, Article 118982. [Google Scholar] [CrossRef] [PubMed]
[38] Wang, T., Jiang, X., Ruan, Y., Li, L. and Chu, L. (2022) The Mechanism of Action of the Combination of Astragalus Membranaceus and Ligusticum Chuanxiong in the Treatment of Ischemic Stroke Based on Network Pharmacology and Molecular Docking. Medicine, 101, e29593. [Google Scholar] [CrossRef] [PubMed]
[39] Cao, J., Lei, L., Wang, K., Sun, J., Qiao, Y., Duan, J., et al. (2021) A Network Pharmacology Approach to Predict the Proangiogenesis Mechanism of Huangqi-Honghua Herb Pair after Cerebral Ischemia. Evidence-Based Complementary and Alternative Medicine, 2021, 1-13. [Google Scholar] [CrossRef] [PubMed]
[40] Zhao, D., Zhang, X., Jin, W., Huang, P., Wan, H. and He, Y. (2024) Efficacy of Astragalus Membranaceus-Carthamus Tinctorius in Cerebral Ischemia/Reperfusion Injury: Insights from Metabolomics and Mass Spectrometry Imaging. Phytomedicine, 133, Article 155881. [Google Scholar] [CrossRef] [PubMed]
[41] Gu, J., Chen, J., Yang, N., Hou, X., Wang, J., Tan, X., et al. (2016) Combination of Ligusticum Chuanxiong and Radix Paeoniae Ameliorate Focal Cerebral Ischemic in MCAO Rats via Endoplasmic Reticulum Stress-Dependent Apoptotic Signaling Pathway. Journal of Ethnopharmacology, 187, 313-324. [Google Scholar] [CrossRef] [PubMed]
[42] 袁蓉, 施伟丽, 信琪琪, 等. 川芎–赤芍药对研究进展[J]. 环球中医药, 2019, 12(5): 808-811.
[43] 付杰, 黄琪, 汪宁. 川芎-红花药对最佳配比及其抗缺血性脑卒中的作用[J]. 中国实验方剂学杂志, 2026, 32(5): 21-31.
[44] Deng, S., Jin, P., Sherchan, P., Liu, S., Cui, Y., Huang, L., et al. (2021) Recombinant CCL17-Dependent CCR4 Activation Alleviates Neuroinflammation and Neuronal Apoptosis through the PI3K/AKT/Foxo1 Signaling Pathway after ICH in Mice. Journal of Neuroinflammation, 18, Article No. 62. [Google Scholar] [CrossRef] [PubMed]
[45] 侯欣宇, 刘竹青, 张亚南, 等. 桃红四物汤对脑缺血再灌注损伤大鼠血脑屏障通透性的保护作用及机制[J]. 安徽中医药大学学报, 2023, 42(4): 81-87.
[46] Wu, D.M., Zhang, Y.T., Lu, J., et al. (2018) Effects of microRNA-129 and Its Target Gene c-Fos on Proliferation and Apoptosis of Hippocampal Neurons in Rats with Epilepsy via the MAPK Signaling Pathway. Journal of Cellular Physiology, 233, 6632-6643. [Google Scholar] [CrossRef] [PubMed]
[47] Deng, Y., Zhang, J., Sun, X., Ma, G., Luo, G., Miao, Z., et al. (2020) miR‑132 Improves the Cognitive Function of Rats with Alzheimer’s Disease by Inhibiting the MAPK1 Signal Pathway. Experimental and Therapeutic Medicine, 20, Article No. 159. [Google Scholar] [CrossRef] [PubMed]
[48] Milovanovic, J., Arsenijevic, A., Stojanovic, B., Kanjevac, T., Arsenijevic, D., Radosavljevic, G., et al. (2020) Interleukin-17 in Chronic Inflammatory Neurological Diseases. Frontiers in Immunology, 11, Article 947. [Google Scholar] [CrossRef] [PubMed]
[49] Kimura-Ohba, S. and Yang, Y. (2016) Oxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic Stroke. Oxidative Medicine and Cellular Longevity, 2016, Article 6927328. [Google Scholar] [CrossRef] [PubMed]
[50] 马娴, 高萍, 刘真一, 等. 补阳还五汤减轻氧化应激保护脑缺血再灌注损伤大鼠血脑屏障的作用研究[J]. 中国比较医学杂志, 2024, 34(3): 75-84+101.
[51] 周啸天, 骆亚莉, 李佳蔚, 等. 补阳还五汤防治缺血性脑卒中作用机制的研究现状[J]. 中国临床药理学杂志, 2022, 38(9): 1011-1015.
[52] 张玉曼, 宋佳, 白德龙, 等. 补阳还五汤对大鼠动脉粥样硬化内皮细胞损伤及血管密度的影响[J]. 中西医结合心脑血管病杂志, 2025, 23(10): 1475-1481.
[53] 郑新杰, 郑丹丹, 张须学. 补阳还五汤联合电针对中风后遗症患者血清IL-6及IL-1β水平影响研究[J]. 中华中医药学刊, 2016, 34(9): 2208-2210.
[54] 范增光, 袁野. 补阳还五汤对动脉粥样硬化模型小鼠SIRT1/HMGB1/NF-κB通路及炎症反应的影响[J]. 中西医结合心脑血管病杂志, 2024, 22(22): 4109-4113.
[55] 李婷婷, 王钦鹏, 刘晓庆, 等. 线粒体自噬对缺血性脑卒中的作用及其机制研究进展[J]. 中风与神经疾病杂志, 2024, 41(1): 41-46.
[56] He, Z., Ning, N., Zhou, Q., Khoshnam, S.E. and Farzaneh, M. (2020) Mitochondria as a Therapeutic Target for Ischemic Stroke. Free Radical Biology and Medicine, 146, 45-58. [Google Scholar] [CrossRef] [PubMed]
[57] 郭丽, 陈恒文, 占存, 等. 加味补阳还五汤调节PINK1/Parkin通路介导的线粒体自噬对脑缺血再灌注小鼠的影响[J/OL]. 中国实验方剂学杂志, 2025: 1-11. https://link.cnki.net/doi/10.13422/j.cnki.syfjx.20251329, 2025-06-17.[CrossRef
[58] 马秀娟, 赵艳萌, 王文良, 等. 补阳还五汤通过AMPK/mTOR/ULK1信号通路调控自噬减轻大鼠脑缺血/再灌注损伤[J]. 中国药理学通报, 2022, 38(1): 147-152.
[59] Wei, K., Wang, P. and Miao, C.Y. (2012) A Double-Edged Sword with Therapeutic Potential: An Updated Role of Autophagy in Ischemic Cerebral Injury. CNS Neuroscience & Therapeutics, 18, 879-886. [Google Scholar] [CrossRef] [PubMed]
[60] Yu, L., Liu, S., Zhou, R., et al. (2022) Atorvastatin Inhibits Neuronal Apoptosis via Activating cAMP/PKA/p-CREB/BDNF Pathway in Hypoxic-Ischemic Neonatal Rats. The FASEB Journal, 36, e22263. [Google Scholar] [CrossRef] [PubMed]
[61] 钟芳芳, 吴承龙, 孙新芳, 等. 补阳还五汤联合依达拉奉对脑缺血再灌注损伤小鼠神经细胞线粒体凋亡途径的影响[J]. 中华全科医学, 2016, 14(11): 1844-1847.
[62] 于修芳, 雷霞, 曹玲, 等. 补阳还五汤对阿尔茨海默病小鼠海马凋亡因子及学习记忆能力的影响[J]. 中国实验方剂学杂志, 2018, 24(3): 109-113.
[63] 杨开令. 补阳还五汤通过Connexin43促进大鼠脑缺血再灌注后神经重塑的机制研究[D]: [硕士学位论文]. 广州: 广州中医药大学, 2020.
[64] 张洋. 补阳还五汤调控自噬相关蛋白影响MCAO大鼠神经再生的作用及机制研究[D]: [硕士学位论文]. 广州: 广州中医药大学, 2018.
[65] Zhao, J., Mo, C., Meng, L.F., et al. (2019) Efficacy and Safety of Buyang Huanwu Decoction for Early-Stage Diabetic Nephropathy: A Meta-Analysis. China Journal of Chinese Materia Medica, 44, 1660-1667.
[66] 杨竣然, 徐子文, 陈遒, 等. 补阳还五汤有效组分抗缺血性脑卒中研究进展[J]. 陕西中医, 2024, 45(7): 995-998.
[67] Lu, Y.K., Yang, H.Y., Liu, X.Z., et al. (2019) Effect of Modified Buyang Huanwu Decoction on Hemorrhagic Transformation after rt-PA Intravenous Thrombolysis in Patients with Super Early Cerebral Infarction. China Journal of Chinese Materia Medica, 44, 1696-1703.
[68] 于彦, 王文科, 袁伟红, 等. 补阳还五汤加减治疗气虚血瘀型脑梗死临床观察[J]. 北京中医药, 2022, 41(6): 662-664.
[69] Hu, X., Li, L., Gong, Y., Fang, Y., Yang, Y., Xu, J., et al. (2022) Buyang Huanwu Decoction Promotes Angiogenesis of Rat Brain Microvascular Endothelial Cells after Oxygen-Glucose Deprivation Reperfusion Injury via Activation of PI3K-AKT Signaling Pathway. Journal of Zhejiang University (Medical Sciences), 51, 544-551. [Google Scholar] [CrossRef] [PubMed]